Sensus Healthcare (SRTS) Set to Announce Quarterly Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) is scheduled to be releasing its earnings data after the market closes on Thursday, May 9th. Analysts expect Sensus Healthcare to post earnings of ($0.04) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Sensus Healthcare (NASDAQ:SRTS) last issued its quarterly earnings results on Thursday, February 8th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.14. The business had revenue of $12.57 million for the quarter, compared to analysts’ expectations of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a return on equity of 1.04%.

Sensus Healthcare Stock Performance

Shares of SRTS opened at $3.76 on Tuesday. Sensus Healthcare has a fifty-two week low of $1.79 and a fifty-two week high of $5.38. The firm has a market cap of $61.63 million, a price-to-earnings ratio of 125.38 and a beta of 0.92. The firm has a 50 day moving average price of $3.67 and a 200-day moving average price of $3.11.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.